Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Lecouvet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Seminars in Musculoskeletal Radiology|December 11, 2020
Detection and Characterization of Musculoskeletal Cancer Using Whole-Body Magnetic Resonance ImagingAmanda Isaac, Frederic Lecouvet, Danoob Dalili, et al.
European Urology|March 18, 2014
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS)Manfred Wirth, Teuvo Tammela, Virgilio Cicalese, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer careFatima Cardoso, Amelia McCartney, Antonio Ponti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2024
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across EuropeMichail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
European Urology|January 18, 2025
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety AnalysisSilke Gillessen, Bertrand Tombal, Fabio Turco, et al.
Frontiers in Oncology|January 27, 2022
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint PaperLaure Fournier, Lioe-Fee de Geus-Oei, Daniele Regge, et al.
Insights Into Imaging|October 4, 2022
Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTCNandita M deSouza, Aad van der Lugt, Christophe M Deroose, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
European Radiology|July 19, 2024
Standardized reporting of spine and sacroiliac joints in axial spondyloarthritis MRI: from the ESSR-Arthritis SubcommitteeWinston J Rennie, Anne Cotten, Anne Grethe Jurik, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Seminars in Musculoskeletal Radiology|December 11, 2020
Detection and Characterization of Musculoskeletal Cancer Using Whole-Body Magnetic Resonance ImagingAmanda Isaac, Frederic Lecouvet, Danoob Dalili, et al.
European Urology|March 18, 2014
Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS)Manfred Wirth, Teuvo Tammela, Virgilio Cicalese, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2023
European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer careFatima Cardoso, Amelia McCartney, Antonio Ponti, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2024
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across EuropeMichail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
European Urology|January 18, 2025
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety AnalysisSilke Gillessen, Bertrand Tombal, Fabio Turco, et al.
Frontiers in Oncology|January 27, 2022
Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint PaperLaure Fournier, Lioe-Fee de Geus-Oei, Daniele Regge, et al.
Insights Into Imaging|October 4, 2022
Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTCNandita M deSouza, Aad van der Lugt, Christophe M Deroose, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
European Radiology|July 19, 2024
Standardized reporting of spine and sacroiliac joints in axial spondyloarthritis MRI: from the ESSR-Arthritis SubcommitteeWinston J Rennie, Anne Cotten, Anne Grethe Jurik, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Pageof 2